These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 21324346
1. Expression of antimicrobial peptides and proteins in etanercept-treated psoriasis patients. Gambichler T, Kobus S, Kobus A, Tigges C, Scola N, Altmeyer P, Kreuter A, Bechara FG, Skrygan M. Regul Pept; 2011 Apr 11; 167(2-3):163-6. PubMed ID: 21324346 [Abstract] [Full Text] [Related]
2. Differential expression of antimicrobial peptides in psoriasis and psoriatic arthritis as a novel contributory mechanism for skin and joint disease heterogeneity. Bierkarre H, Harder J, Cuthbert R, Emery P, Leuschner I, Mrowietz U, Hedderich J, McGonagle D, Gläser R. Scand J Rheumatol; 2016 Apr 11; 45(3):188-96. PubMed ID: 26599663 [Abstract] [Full Text] [Related]
3. Visfatin enhances the production of cathelicidin antimicrobial peptide, human β-defensin-2, human β-defensin-3, and S100A7 in human keratinocytes and their orthologs in murine imiquimod-induced psoriatic skin. Hau CS, Kanda N, Noda S, Tatsuta A, Kamata M, Shibata S, Asano Y, Sato S, Watanabe S, Tada Y. Am J Pathol; 2013 May 11; 182(5):1705-17. PubMed ID: 23499548 [Abstract] [Full Text] [Related]
4. Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. Harder J, Dressel S, Wittersheim M, Cordes J, Meyer-Hoffert U, Mrowietz U, Fölster-Holst R, Proksch E, Schröder JM, Schwarz T, Gläser R. J Invest Dermatol; 2010 May 11; 130(5):1355-64. PubMed ID: 20107483 [Abstract] [Full Text] [Related]
5. Expression of antimicrobial peptides in different subtypes of cutaneous lupus erythematosus. Kreuter A, Jaouhar M, Skrygan M, Tigges C, Stücker M, Altmeyer P, Gläser R, Gambichler T. J Am Acad Dermatol; 2011 Jul 11; 65(1):125-33. PubMed ID: 21353331 [Abstract] [Full Text] [Related]
6. TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept. Caldarola G, De Simone C, Carbone A, Tulli A, Amerio P, Feliciani C. Int J Immunopathol Pharmacol; 2009 Jul 11; 22(4):961-6. PubMed ID: 20074459 [Abstract] [Full Text] [Related]
7. Significant upregulation of antimicrobial peptides and proteins in lichen sclerosus. Gambichler T, Skrygan M, Tigges C, Kobus S, Gläser R, Kreuter A. Br J Dermatol; 2009 Nov 11; 161(5):1136-42. PubMed ID: 19558556 [Abstract] [Full Text] [Related]
8. Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa. Emelianov VU, Bechara FG, Gläser R, Langan EA, Taungjaruwinai WM, Schröder JM, Meyer KC, Paus R. Br J Dermatol; 2012 May 11; 166(5):1023-34. PubMed ID: 22136668 [Abstract] [Full Text] [Related]
15. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY. N Engl J Med; 2002 Oct 10; 347(15):1151-60. PubMed ID: 12374875 [Abstract] [Full Text] [Related]
16. Differential expression pattern of antimicrobial peptides in nasal mucosa and secretion. Laudien M, Dressel S, Harder J, Gläser R. Rhinology; 2011 Mar 10; 49(1):107-11. PubMed ID: 21468384 [Abstract] [Full Text] [Related]
17. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study. Mazzotta A, Esposito M, Costanzo A, Chimenti S. Am J Clin Dermatol; 2009 Mar 10; 10(5):319-24. PubMed ID: 19658444 [Abstract] [Full Text] [Related]